Non-Invasive Prenatal Testing Market to Reach $10.88 Billion by 2027

The global “Non-Invasive Prenatal Testing ” Market, size is projected to reach USD 10.88 billion by the end of 2027. The presence of several large scale companies will have a positive impact on the growth of the market in the coming years. According to a report published by Fortune Business Insights, titled “Non-Invasive Prenatal Testing (NIPT) Market Size, Share COVID-19 Impact Analysis, By Product (Instruments, and Consumables Reagents), Technology (Next Generation Sequencing, Microarray, PCR, and Rolling Circular Amplification), End User (Hospitals, and Clinical Laboratories) Regional Forecast, 2020-2027,” the market was worth USD 2.95 billion in 2019 and will exhibit a CAGR of 17.8% during the forecast period, 2020-2027.

Non-Invasive Prenatal Testing (NIPT) are used to analyze cell-free fetal DNA that detects whether the fetus will be born with certain genetic abnormalities. This process analyzes small fragments of a DNA that circulate in the blood of a pregnant woman. NIPT is described as non-invasive as only the blood of the pregnant woman is studied and it possesses no risk to the fetus. The massive investments in the development of efficient NIPT tools will bode well for the growth of the overall NIPT market in the foreseeable future. The presence of several large scale companies operating in several countries across the world will have a huge impact on the growth of the overall market in the foreseeable future. The reducing costs of genetic testing will bode well for the growth of the NIPT market in the coming years.

Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/sample/non-invasive-prenatal-testing-market-100998

Industry Developments:

July 2019: Invitae announced that it will be acquiring Singular Bio, a company specializing in single-molecule cell-free DNA analysis. The collaboration will be aimed at developing non-invasive prenatal test.

What does the Report Include?

The market report includes quantitative and qualitative analysis of several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers the different regions, which are contributing to the growth of the market. It includes the competitive landscape that involves leading companies and adoption of strategies by them to introduce new products, announce partnerships, and collaboration that will contribute to the growth of the market between 2020 and 2027. Moreover, the research analyst has adopted several research methodologies such as PESTEL and SWOT analysis to extract information about the current trends and industry developments that will drive the market growth in the forthcoming years.

An Overview of the Impact of COVID-19 on this Market :

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.

industry developments that will drive the market growth in the forthcoming years.

For more information visit :

https://www.fortunebusinessinsights.com/industry-reports/non-invasive-prenatal-testing-market-100998

Covid-19 Pandemic to Have a Minimal Impact on NIPT Manufacturers

The Covid-19 pandemic has had an adverse effect on several industries across the world. The efforts taken to curb the spread of the disease have had a damaging impact on several industries across the world. The rapidly rising cases of coronavirus across the world have urged healthcare professionals to focus on tools associated with the treatment of the disease and deviated attention from other concepts such as NIPT. As a result, the Covid-19 pandemic has had a minimal impact on the non-invasive prenatal market in the past few months.

Increasing Number of Company Mergers and Acquisitions will have a Huge Impact on Market Growth

The report encompasses several factors that have contributed to the growth of the overall market in recent years. Among all factors, the increasing number of company collaborations has made the highest impact on market growth. In March 2019, Natera announced that it has formed a strategic partnership with QIAGEN. Through this collaboration, the company will look to develop a breakthrough cell-free DNA assays. The companies will look to capitalize on QIAGEN’s GeneReader NGS System. Such collaborations are aimed at advancing in the NIPT sector and companies will look to maximize the use of technologically advanced concepts. Natera’s collaboration with QIAGEN is among the major company collaborations of recent times that have had a major say on the growth of the overall market.

North America to Emerge Dominant; Presence of Several Diagnostic Centres to Aid Growth

The report analyses the ongoing market trends across five major regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among all regions, the market in North America is projected to emerge dominant in the coming years. The increasing penetration of non-invasive prenatal testing will bode well for the growth of the regional market. The increasing incidence of down syndrome among babies, especially in the United States will have a massive impact on the growth of the regional market. The increasing investments in the research and development of efficient NIPT by large scale companies in this region will emerge in favor of market growth. As of 2019, the market in North America was worth USD 1.52 billion and this value is projected to increase further in the coming years.

List of companies profiled in the report: